Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14452219 | 0.89 | MEN1 (0.60) | MEN1KMT2AMAPTTDP1KDM4E | |
| SCHEMBL21795198 | 0.86 | MEN1 (0.64) | MEN1KMT2AMAPTTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL22321960 | 0.79 | MEN1 (0.97) | MEN1KMT2AMAPTTDP1KDM4E | |
| SCHEMBL29499501 | 0.77 | MEN1 (1.00) | MEN1KMT2AMAPTTDP1KDM4E | |
| Iodide SCHEMBL22542621 | 0.76 | MEN1 (0.97) | MEN1KMT2AMAPTTDP1KDM4E | |
| Iodide SCHEMBL29456898 | 0.76 | MEN1 (0.97) | MEN1KMT2AMAPTTDP1KDM4E | |
| SCHEMBL11947486 | 0.73 | MEN1 (0.64) | MEN1KMT2AMAPTTDP1KDM4E | |
| Hydrochloric Acid SCHEMBL4422818 | 0.73 | MEN1 (0.59) | MEN1KMT2AMAPTTDP1KDM4E | |
| SCHEMBL4417719 | 0.71 | MEN1 (0.60) | MEN1KMT2AMAPTTDP1KDM4E | |
| SCHEMBL4422814 | 0.70 | KMT2A (0.59) | MEN1KMT2AMAPTTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1646609-B1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-14 | — | — | EP | disclosed |
| US-7262306-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20060199223-A1 | storage stability; immunoassays | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| EP-1646609-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | Roche Diagnostics GmbH (DE) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005005385-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-1496050-A1 | Novel chemiluminescent compounds and their use | Roche Diagnostics GmbH (DE) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060199223-A1 | storage stability; immunoassays | SHBG, SELL, XIAP | MEN1 2683/4885KMT2A 4213/4885MAPT 1849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.